Finally, we demonstrate that deletion of the C−C chemokine receptor type-2 gene (Ccr2) from the host of allografted tumours, or using a pharmacological approach by treating tumour-bearing mice with two CSF1R inhibitors, significantly decreases survival time of tumour-bearing mice compared to vehicle treatment. The gene discussed is CSF1R; the disease is neoplasm.